{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:43:23Z","timestamp":1793339003440,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.dld.2017.12.006","type":"journal-article","created":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T13:21:52Z","timestamp":1513603312000},"page":"124-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Gastrointestinal lymphomas: French Intergroup clinical practice recommendations for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFH)"],"prefix":"10.1016","volume":"50","author":[{"given":"Tamara","family":"Matysiak-Budnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Fabiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Hennequin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Thieblemont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Malamut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Cadiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bouch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Ruskon\u00e9-Fourmestraux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"March (1)","key":"10.1016\/j.dld.2017.12.006_bib0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.beha.2004.08.003","article-title":"Update on MALT lymphomas","volume":"18","author":"Isaacson","year":"2005","journal-title":"Best Pract Res Clin Haematol"},{"issue":"July (7)","key":"10.1016\/j.dld.2017.12.006_bib0010","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/j.1572-0241.2008.01794.x","article-title":"Changing epidemiology and risk factors for gastrointestinal non-Hodgkin\u2019s lymphoma in a North American population: population-based study","volume":"103","author":"Andrews","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"December (12)","key":"10.1016\/j.dld.2017.12.006_bib0015","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1111\/j.1572-0241.2006.00854.x","article-title":"Incidence and management of primary malignant small bowel cancers: a well-defined French population study","volume":"101","author":"Lepage","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.dld.2017.12.006_bib0020","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/0016-5085(93)91061-L","article-title":"Primary digestive tract lymphoma: a prospective multicentric study of 91 patients. Groupe d'Etude des Lymphomes Digestifs","volume":"105","author":"Ruskone-Fourmestraux","year":"1993","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.dld.2017.12.006_bib0025","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1053\/gast.2000.19579","article-title":"Primary gastric B-cell lymphoma: results of a prospective multicenter study: The German\u2013Austrian Gastrointestinal Lymphoma Study Group","volume":"119","author":"Fischbach","year":"2000","journal-title":"Gastroenterology"},{"issue":"18","key":"10.1016\/j.dld.2017.12.006_bib0030","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1200\/JCO.2001.19.18.3861","article-title":"Primary gastrointestinal non-Hodgkin\u2019s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01\/92","volume":"19","author":"Koch","year":"2001","journal-title":"J Clin Oncol"},{"issue":"June (6)","key":"10.1016\/j.dld.2017.12.006_bib0035","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/gut.2010.224949","article-title":"EGILS consensus report: gastric extranodal marginal zone B-cell lymphoma of MALT","volume":"60","author":"Ruskone-Fourmestraux","year":"2011","journal-title":"Gut"},{"issue":"October (Suppl. 6)","key":"10.1016\/j.dld.2017.12.006_bib0040","doi-asserted-by":"crossref","first-page":"vi144","DOI":"10.1093\/annonc\/mdt343","article-title":"Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Zucca","year":"2013","journal-title":"Ann Oncol"},{"issue":"April (4)","key":"10.1016\/j.dld.2017.12.006_bib0045","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/annonc\/mds643","article-title":"ESMO consensus conferences: guidelines on malignant lymphoma. Part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma","volume":"24","author":"Dreyling","year":"2013","journal-title":"Ann Oncol"},{"issue":"November (11)","key":"10.1016\/j.dld.2017.12.006_bib0050","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.dld.2013.05.008","article-title":"Primary intestinal B-cell lymphoma: a prospective multicentre clinical study of 91 cases","volume":"45","author":"Matysiak-Budnik","year":"2013","journal-title":"Dig Liver Dis"},{"issue":"January (1)","key":"10.1016\/j.dld.2017.12.006_bib0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/00365520410009438","article-title":"Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori: scratch and win","volume":"40","author":"Franco","year":"2005","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.dld.2017.12.006_bib0060","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1572-0241.2003.t01-1-07264.x","article-title":"Which test to use to detect Helicobacter pylori infection in patients with low-grade gastric mucosa-associated lymphoid tissue lymphoma?","volume":"98","author":"Lehours","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"January (1)","key":"10.1016\/j.dld.2017.12.006_bib0065","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection\u2014the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"issue":"May (20)","key":"10.1016\/j.dld.2017.12.006_bib0070","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"January (1)","key":"10.1016\/j.dld.2017.12.006_bib0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/bjh.12078","article-title":"Gela histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice","volume":"160","author":"Copie-Bergman","year":"2013","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.dld.2017.12.006_bib0080","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/gast.2002.33047","article-title":"T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication","volume":"122","author":"Liu","year":"2002","journal-title":"Gastroenterology"},{"issue":"February (2)","key":"10.1016\/j.dld.2017.12.006_bib0085","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/10428190903431820","article-title":"Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up","volume":"51","author":"Levy","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"October (4)","key":"10.1016\/j.dld.2017.12.006_bib0090","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.gie.2008.05.021","article-title":"Gastric mucosa-associated lymphoid tissue lymphoma: a challenge for endoscopy","volume":"68","author":"Fischbach","year":"2008","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"10.1016\/j.dld.2017.12.006_bib0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/gut.48.3.297","article-title":"Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment","volume":"48","author":"Ruskone-Fourmestraux","year":"2001","journal-title":"Gut"},{"issue":"December (12)","key":"10.1016\/j.dld.2017.12.006_bib0100","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1055\/s-2005-921045","article-title":"Capsule endoscopy in gastrointestinal lymphomas","volume":"37","author":"Flieger","year":"2005","journal-title":"Endoscopy"},{"issue":"September (27)","key":"10.1016\/j.dld.2017.12.006_bib0105","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"issue":"September (3)","key":"10.1016\/j.dld.2017.12.006_bib0110","doi-asserted-by":"crossref","first-page":"308","DOI":"10.5009\/gnl.2011.5.3.308","article-title":"Role of F-FDG PET scans in patients with Helicobacter pylori-infected gastric low-grade MALT lymphoma","volume":"5","author":"Song","year":"2011","journal-title":"Gut Liver"},{"issue":"June (6)","key":"10.1016\/j.dld.2017.12.006_bib0115","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/gut.52.6.912","article-title":"Paris staging system for primary gastrointestinal lymphomas","volume":"52","author":"Ruskone-Fourmestraux","year":"2003","journal-title":"Gut"},{"issue":"May (17)","key":"10.1016\/j.dld.2017.12.006_bib0120","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3748\/wjg.v16.i17.2158","article-title":"Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma","volume":"16","author":"Park","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"May (5)","key":"10.1016\/j.dld.2017.12.006_bib0125","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/gut.2005.083022","article-title":"Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas","volume":"55","author":"Raderer","year":"2006","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.dld.2017.12.006_bib0130","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bpg.2009.05.008","article-title":"The impact of EUS in primary gastric lymphoma","volume":"23","author":"Janssen","year":"2009","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.dld.2017.12.006_bib0135","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0016-5107(02)70119-3","article-title":"Diagnostic accuracy of EUS in the local staging of primary gastric lymphoma: results of a prospective, multicenter study comparing EUS with histopathologic stage","volume":"56","author":"Fischbach","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.dld.2017.12.006_bib0140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cgh.2009.07.017","article-title":"Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma","volume":"8","author":"Zullo","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2017.12.006_bib0145","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1182\/blood.V98.4.1182","article-title":"T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10","volume":"98","author":"Liu","year":"2001","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.dld.2017.12.006_bib0150","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1136\/gut.2006.096420","article-title":"Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series","volume":"56","author":"Fischbach","year":"2007","journal-title":"Gut"},{"issue":"June (2)","key":"10.1016\/j.dld.2017.12.006_bib0155","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12032-009-9207-y","article-title":"Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter pylori therapy: a pooled-data analysis","volume":"27","author":"Zullo","year":"2010","journal-title":"Med Oncol"},{"issue":"4","key":"10.1016\/j.dld.2017.12.006_bib0160","first-page":"372","article-title":"The role of surgery in the treatment of gastrointestinal lymphomas other than low-grade MALT lymphomas","volume":"85","author":"Gobbi","year":"2000","journal-title":"Haematologica"},{"issue":"February (2)","key":"10.1016\/j.dld.2017.12.006_bib0165","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.radonc.2008.12.004","article-title":"Favorable outcomes of radiotherapy for early-stage mucosa-associated lymphoid tissue lymphoma","volume":"90","author":"Tomita","year":"2009","journal-title":"Radiother Oncol"},{"issue":"November (22)","key":"10.1016\/j.dld.2017.12.006_bib0170","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1200\/JCO.2003.06.085","article-title":"Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome","volume":"21","author":"Tsang","year":"2003","journal-title":"J Clin Oncol"},{"issue":"June (3)","key":"10.1016\/j.dld.2017.12.006_bib0175","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.radonc.2008.02.012","article-title":"Long-term results of stomach-conserving therapy in gastric MALT lymphoma","volume":"87","author":"Vrieling","year":"2008","journal-title":"Radiother Oncol"},{"issue":"May (5)","key":"10.1016\/j.dld.2017.12.006_bib0180","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/annonc\/mds623","article-title":"Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group study","volume":"24","author":"Wirth","year":"2013","journal-title":"Ann Oncol"},{"issue":"October (1)","key":"10.1016\/j.dld.2017.12.006_bib0185","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.radonc.2015.08.029","article-title":"Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: results of a prospective study with a long term follow-up","volume":"117","author":"Ruskone-Fourmestraux","year":"2015","journal-title":"Radiother Oncol"},{"issue":"January (1)","key":"10.1016\/j.dld.2017.12.006_bib0190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4143\/crt.2014.46.1.33","article-title":"The role of radiotherapy in the treatment of gastric mucosa-associated lymphoid tissue lymphoma","volume":"46","author":"Nam","year":"2014","journal-title":"Cancer Res Treat"},{"issue":"February (5)","key":"10.1016\/j.dld.2017.12.006_bib0195","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1200\/JCO.2011.40.6272","article-title":"Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 randomized study","volume":"31","author":"Zucca","year":"2013","journal-title":"J Clin Oncol"},{"issue":"January (9759)","key":"10.1016\/j.dld.2017.12.006_bib0200","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0140-6736(10)62175-7","article-title":"Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial","volume":"377","author":"Salles","year":"2011","journal-title":"Lancet"},{"issue":"March (3)","key":"10.1016\/j.dld.2017.12.006_bib0205","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3324\/haematol.12120","article-title":"Secondary malignancies after treatment for indolent non-Hodgkin\u2019s lymphoma: a 16-year follow-up study","volume":"93","author":"Sacchi","year":"2008","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.dld.2017.12.006_bib0210","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/annonc\/mdf178","article-title":"Chemotherapy for management of localised high-grade gastric B-cell lymphoma: how much is necessary?","volume":"13","author":"Raderer","year":"2002","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.dld.2017.12.006_bib0215","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1053\/gast.2002.34591","article-title":"Helicobacter pylori eradication therapy in primary high-grade gastric MALT lymphoma","volume":"123","author":"Fischbach","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.12.006_bib0220","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/1471-2407-11-321","article-title":"Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)","volume":"11","author":"Kim","year":"2011","journal-title":"BMC Cancer"},{"issue":"February (1)","key":"10.1016\/j.dld.2017.12.006_bib0225","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bpg.2009.12.001","article-title":"Primary gastrointestinal tract mantle cell lymphoma as multiple lymphomatous polyposis","volume":"24","author":"Ruskone-Fourmestraux","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.dld.2017.12.006_bib0230","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0016-5085(97)70212-9","article-title":"Multiple lymphomatous polyposis of the gastrointestinal tract: prospective clinicopathologic study of 31 cases. Groupe D'etude des Lymphomes Digestifs","volume":"112","author":"Ruskone-Fourmestraux","year":"1997","journal-title":"Gastroenterology"},{"issue":"July (3)","key":"10.1016\/j.dld.2017.12.006_bib0235","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/j.seminhematol.2011.03.008","article-title":"Treatment of elderly patients with mantle cell lymphoma","volume":"48","author":"Kluin-Nelemans","year":"2011","journal-title":"Semin Hematol"},{"issue":"April (4)","key":"10.1016\/j.dld.2017.12.006_bib0240","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/annonc\/mdg168","article-title":"Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review","volume":"14","author":"Damaj","year":"2003","journal-title":"Ann Oncol"},{"issue":"October (9)","key":"10.1016\/j.dld.2017.12.006_bib0245","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/MCG.0b013e3180f62b12","article-title":"Primary gastrointestinal follicular lymphoma: a clinicopathologic study of 13 cases from Taiwan","volume":"42","author":"Huang","year":"2008","journal-title":"J Clin Gastroenterol"},{"issue":"November (5)","key":"10.1016\/j.dld.2017.12.006_bib0250","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2559.2005.02225.x","article-title":"Lymphomatous polyposis of the gastrointestinal tract, including mantle cell lymphoma, follicular lymphoma and mucosa-associated lymphoid tissue lymphoma","volume":"47","author":"Kodama","year":"2005","journal-title":"Histopathology"},{"issue":"January (1)","key":"10.1016\/j.dld.2017.12.006_bib0255","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1079-2104(97)90084-6","article-title":"Clinical evaluation of the use of low-intensity ultrasound in the treatment of recurrent aphthous stomatitis","volume":"83","author":"Brice","year":"1997","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"April (4)","key":"10.1016\/j.dld.2017.12.006_bib0260","first-page":"339","article-title":"Non Hodgkin\u2019s lymphoma in adolescents","volume":"94","author":"Patte","year":"2007","journal-title":"Bull Cancer"},{"key":"10.1016\/j.dld.2017.12.006_bib0265","series-title":"Handbook of mucosal immunol","first-page":"425","article-title":"Alpha chain disease and related lymphoproliferative disorders","author":"Rambaud","year":"1994"},{"issue":"January (3)","key":"10.1016\/j.dld.2017.12.006_bib0270","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa031887","article-title":"Immunoproliferative small intestinal disease associated with Campylobacter jejuni","volume":"350","author":"Lecuit","year":"2004","journal-title":"N Engl J Med"},{"issue":"April (4)","key":"10.1016\/j.dld.2017.12.006_bib0275","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.cgh.2013.11.028","article-title":"Small intestinal CD4+ T-cell lymphoma is a heterogenous entity with common pathology features","volume":"12","author":"Malamut","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2017.12.006_bib0280","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/gut.45.5.662","article-title":"The clinicopathological features of extensive small intestinal CD4 T cell infiltration","volume":"45","author":"Carbonnel","year":"1999","journal-title":"Gut"},{"issue":"9225","key":"10.1016\/j.dld.2017.12.006_bib0285","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(00)02481-8","article-title":"Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma: French Coeliac Disease Study Group","volume":"356","author":"Cellier","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.dld.2017.12.006_bib0290","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000369519","article-title":"Refractory celiac disease: epidemiology and clinical manifestations","volume":"33","author":"Malamut","year":"2015","journal-title":"Dig Dis"},{"issue":"April (4)","key":"10.1016\/j.dld.2017.12.006_bib0295","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2011.12.040","article-title":"Enteropathy-associated T-cell lymphoma complicating an autoimmune enteropathy","volume":"142","author":"Malamut","year":"2012","journal-title":"Gastroenterology"},{"issue":"November (5)","key":"10.1016\/j.dld.2017.12.006_bib0300","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1053\/gast.2002.36585","article-title":"Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis","volume":"123","author":"Askling","year":"2002","journal-title":"Gastroenterology"},{"issue":"May (5)","key":"10.1016\/j.dld.2017.12.006_bib0305","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.dld.2012.12.001","article-title":"Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study","volume":"45","author":"Malamut","year":"2013","journal-title":"Dig Liver Dis"},{"issue":"November (31)","key":"10.1016\/j.dld.2017.12.006_bib0310","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1200\/JCO.2005.02.3903","article-title":"Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication","volume":"23","author":"Wundisch","year":"2005","journal-title":"J Clin Oncol"},{"issue":"August (8)","key":"10.1016\/j.dld.2017.12.006_bib0315","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/annonc\/mdi242","article-title":"Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma?","volume":"16","author":"Copie-Bergman","year":"2005","journal-title":"Ann Oncol"},{"issue":"November (16)","key":"10.1016\/j.dld.2017.12.006_bib0320","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/j.ejca.2008.07.005","article-title":"Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study","volume":"44","author":"Capelle","year":"2008","journal-title":"Eur J Cancer"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865817313233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865817313233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T09:09:53Z","timestamp":1603530593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865817313233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1590865817313233"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2017.12.006","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrointestinal lymphomas: French Intergroup clinical practice recommendations for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFH)","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2017.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}